Genesis Biotech manufactures a benchtop sequencer and SaaS analysis platform for pathogen detection in clinical and research settings. The Brisbane-based team, spun out of UQ's Queensland Brain Institute, has FDA clearance and TGA approval pending. The system returns results in 4 hours versus 24-48 hours for traditional labs.